According to BIO-key International 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.389038. At the end of 2024 the company had a P/E ratio of -0.7634.
Year | P/E ratio | Change |
---|---|---|
2024 | -0.7634 | |
2022 | -0.4758 | -86.44% |
2021 | -3.51 | 208.94% |
2020 | -1.14 | 2.4% |
2019 | -1.11 | 15.32% |
2018 | -0.9615 | -55.45% |
2017 | -2.16 | -26.69% |
2016 | -2.94 | -44.79% |
2015 | -5.33 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() Insight Enterprises
NSIT | 24.6 | -6,432.16% | ๐บ๐ธ USA |
![]() TD Synnex SNX | 17.2 | -4,533.19% | ๐บ๐ธ USA |
![]() SolarWinds
SWI | 81.6 | -21,080.19% | ๐บ๐ธ USA |
![]() Trust Stamp IDAI | -0.3057 | -21.41% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.